Nordic Capital

News, insights, analysis and data

← Back to Nordic Capital profile

Nordic Capital related stories

All articles and analysis

  • Europe
    PEI Staff- 30 December 2012
  • Bure sells Nordic Capital funds
    PEI Staff- 30 December 2012

    The Swedish private equity house has sold its interests in Noric Capital’s buyout funds II, III and IV to an unnamed secondaries investor.

  • Baker, Nordic buy Vivendi TV unit
    PEI Staff- 30 December 2012

    US-based Baker Capital has teamed with Nordic Capital to acquire Vivendi Universal’s Nordic pay television provider Canal+ Television.

  • Nordic Capital makes Dyvig partner
    PEI Staff- 30 December 2012

    The Swedish private equity firm has hired former Morgan Stanley managing director Christian Dyvig as a partner at its Danish office.

  • GM’s Flynn leaves for Coller
    PEI Staff- 30 December 2012

    London-based Coller Capital has hired Susan Flynn of GM Asset Management to help invest the firm’s $2.5bn global secondaries fund.

  • Tabet in charge of Citigroup’s FEG
    PEI Staff- 30 December 2012

    London-based Kamal Tabet has been appointed global head of Citigroup’s Financial Entrepreneurs Group, the bank’s private equity advisory and fund placement business.

  • Tabet in charge of Citigroup’s FEG
    PEI Staff- 30 December 2012

    London-based Kamal Tabet has been appointed global head of Citigroup’s Financial Entrepreneurs Group, the bank’s private equity advisory and fund placement business.

  • Permira to open Stockholm office
    PEI Staff- 30 December 2012

    Kurt Björklund is to head up Permira’s new presence in the Nordic region, working alongside the newly appointed Ole Oftedal, who joins as an industrial partner.

  • Charterhouse holds second close
    PEI Staff- 30 December 2012

    The UK buyout firm has now raised over E2bn, the largest amount raised for a European fund launched in 2002.

  • Nordic completes Nycomed exit
    PEI Staff- 30 December 2012

    CSFB’s private equity division has acquired Nordic Capital’s Danish pharmaceutical business in one of Europe’s largest secondary transactions.